NEXGEL Announces 1-for-20 Reverse Stock Split Effectiveness

Split-adjusted trading to begin on The Nasdaq Capital Market at market open on October 12, 2026 LANGHORNE, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a company with a patient centric medical technology sales and marketing team working closely with clinicians to provide solutions that drive better outcomes, streamline care, and elevate the patient experience, today announced that its common stock, par value $0.001 per share (the “Common Stock